EMMA LAMBERSON: Open Payments
NPI 1598168544 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 14 payments from 7 companies in 2025. Trend: 2023 $448 · 2024 $312 · 2025 $379
Food & beverage: $378Education: $2
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Vifor Pharma, Inc. | 2 | $50 |
| Calliditas Therapeutics US Inc. | 1 | $32 |
| Ardelyx, Inc. | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: Veltassa, TARPEYO, IBSRELA, ACTHAR, JARDIANCE, Filspari.
Industry payments across AR — which companies pay providers there.
